Fulvestrant, Inavolisib, and Palbociclib

About

Membership operator: AND

Therapies: 3

Therapies

Fulvestrant (tx:ncit:C1379)

Inavolisib (tx:ncit:C132166)

Palbociclib (tx:ncit:C49176)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy group.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
FDA (4) HC (1) ER positive, HER2-negative, PIK3CA oncogenic variants Invasive Breast Carcinoma Fulvestrant, Inavolisib, Palbociclib
FDA (4) HC (1) HER2-negative, PIK3CA oncogenic variants, PR positive Invasive Breast Carcinoma Fulvestrant, Inavolisib, Palbociclib
FDA (4) HC (1) ER positive, HER2-negative, PIK3CA oncogenic variants, PR positive Invasive Breast Carcinoma Fulvestrant, Inavolisib, Palbociclib